New Delhi, March 17 (IANS) Aurobindo Pharma on Tuesday said that the US Food and Drug Administration (USFDA) has classified one of its subsidiary units as “Official Action Indicated” (OAI) following an inspection conducted last year.In a regulatory filing, the company said that the USFDA inspected Unit-II of Eugia Pharma Specialities Limited, its wholly-owned subsidiary, located in Bhiwadi, Rajasthan, between November 3 and 14, 2025.At the end of the inspection, the regulator had issued a Fo…
Trending
- Elra Kaaleliyatte Kaala Review: A Soulful Ode to Timelessness That Charms Despite Its Flaws
- Sugriva Movie Review (2026): A Gripping Emotional Thriller That Hits Hard
- Licence Review (2026): Masoom Sharma Delivers a Gripping Haryanvi Crime Drama
- Bhagubai (2026) Review: Nirmiti Sawant Shines in This Heartfelt Marathi Village Drama
- Ginny Wedss Sunny 2 Review (2026): A Warm and Relatable Ride Through the Chaos of Arranged Marriage
- Jerax Review (2026): Nagabhushan’s Supernatural Thriller Is a Wildly Entertaining Ride
- Battle (2026) Movie Review — Tamil Rap Drama Finds Its Rhythm in Flashes
- Madhuvidhu Movie Review (2026): Sharaf U Dheen’s Charm Lights Up This Warm Malayalam Rom-Com